scholarly journals Opioid Medication Use Among Chronic Non-Cancer Pain Patients Assessed with a Modified Drug Effects Questionnaire and the Association with Opioid Use Disorder

2020 ◽  
Vol Volume 13 ◽  
pp. 2697-2705
Author(s):  
Joseph A Boscarino ◽  
Carrie A Withey ◽  
Ryan J Dugan ◽  
Yirui Hu ◽  
Jessica Auciello ◽  
...  
Keyword(s):  
Cancer Pain ◽  
Medication Use ◽  
Drug Effects ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Opioid Medication ◽  
Pain Patients

scholarly journals Opioid Use Disorders among Patients on Long-Term Morphine for Management of Chronic Cancer Pain: A Pilot Study from a Tertiary Palliative Care Facility

2021 ◽  
Vol 27 ◽  
pp. 264-268
Author(s):  
Nandan Choudhary ◽  
Shalini Singh ◽  
Puneet Rathore ◽  
Atul Ambekar ◽  
Sushma Bhatnagar
Keyword(s):  
Cancer Pain ◽  
Cancer Patients ◽  
Opioid Analgesic ◽  
Care Facility ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Chronic Cancer Pain ◽  
Opioid Use Disorders ◽  
Pain Patients

Objectives: Long-term opioid use can be associated with misuse and addiction. In the backdrop of increasing burden of cancer patients in India, it is important to assess the rate of opioid use disorders among those with chronic cancer pain. The objectives were to measure the rate of opioid use disorder in chronic cancer pain patients being managed with morphine and to assess its association with demographic and clinical characteristics. Materials and Methods: A cross-sectional study was conducted on chronic cancer pain patients who were prescribed morphine for ≥12 months, dosage of ≥60 mg/day. They were assessed using MINI version 7.0.0, WHO-ASSIST Hindi questionnaire, Addiction Behavior Checklist, and DSM-5 for opioid use disorder. Results: Forty patients who were treated with morphine for a total of 1479 months participated. The average morphine consumption was 159.50 ± 327.90 mg/day. Six (15%) showed possible inappropriate opioid analgesic use and none of the patients had opioid use disorder. Conclusion: This study reports the absence of opioid use disorder due to vigilant use of morphine in chronic cancer patients.

Abuse of Opioids and Prescription Medications

2016 ◽  
Author(s):  
Isis Burgos-Chapman ◽  
Louis A. Trevisan ◽  
Kevin Sevarino
Keyword(s):  
Pain Treatment ◽  
The Elderly ◽  
Pain Medication ◽  
Opioid Use Disorder ◽  
Prescription Medications ◽  
Opioid Use ◽  
Opioid Medication ◽  
Medication Misuse ◽  
Chronic Pain Treatment

This chapter reviews an under-recognized aspect of geriatrics. The elderly population is growing in number, as is the proportion of aging baby-boomers at high risk for pain medication misuse and opioid use disorders. Given the widespread use of opioids in pain management, one can expect that problems with opioid use will increase among the elderly in the coming years. We describe the magnitude of the problem and discuss the importance of risk-stratification to identify which older patients are at elevated risk to develop problems with opioids. We examine the role of opioids in chronic pain treatment and the pitfalls of their use in the elderly. Finally, we provide general guidelines for the treatment of pain medication misuse and/or an opioid use disorder in the elderly. Opioid medication misuse and use disorders should be on every practitioner’s radar as a possible reason for problems surfacing in the elderly patient.

Opioid use disorder and chronic pain: challenges for palliative care practice

2019 ◽  
Vol 25 (9) ◽  
pp. 453-457
Author(s):  
Brenda Peters-Watral
Keyword(s):  
Chronic Pain ◽  
Palliative Care ◽  
Substance Use ◽  
Pain Management ◽  
Cancer Pain ◽  
Opioid Use Disorder ◽  
Care Practice ◽  
Care Providers ◽  
Opioid Use ◽  
Multiple Cancer

Along with a well-documented increase in opioid use disorder (OUD) and a rapidly escalating rate of fatal overdose in North America, inadequate management of chronic pain remains a pervasive problem. The increasing number of individuals living with OUD also experience multiple cancer risk factors, which are related to their substance use, while people with cancer diagnoses have similar risks of current or past addiction as the general population. Recent pain guidelines focus on chronic non-cancer pain and do not include recommendations for cancer pain management. Managing cancer pain at the end of life is more challenging in people with current or past substance use disorder (SUD), especially OUD. Addressing these challenges requires confronting stigmas and stereotypes, building knowledge among palliative care providers and assessing the risks and benefits of opioids for pain management on an individual basis in order to continue to provide the holistic care.

scholarly journals Pluri Psychopathology and Risk of Opioid Use Disorder

2018 ◽  
Vol 3 (7) ◽  
Keyword(s):  
Risk Factors ◽  
Chronic Pain ◽  
Risk Factor ◽  
Cancer Pain ◽  
Gender Dysphoria ◽  
Psychiatric Comorbidity ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Transdermal Fentanyl ◽  
Case Presentation

Background: Psychiatric comorbidty is an important risk factor when predicting risk of opioid use disorder in chronic non-cancer pain. We present a case with gender dysphoria, in wich psychiatric comorbidity was not taken into account for de prescription of pharmacological treatment for pain. Case presentation: We report the case of a 51-year-old man with gender dysphoria, personality disorder, chronic pain disorder and opioid use disorder. For the last 9 years he has taken continuousy transdermal fentanyl prescribed by chronic non-cancer pain. Despite of presenting a pluripathology that discouraged the use of opioids in this patient, throughout his evolution, he has gone to different non-psychiatrists and has shown himself with a querulous, confictive and demanding attitude, so that he managed to keep on raising his dose of prescribed opioids. Conclusions: This case shows the importance of knowing the risk factors of consumption due to the use of opioids patients with chronic non-cancer pain, the importance of psychiatric comorbidity associated with prognosis and the neeed to know exactly how opioids are managed by some prescribers, as well as to carry out an interdisciplinary therapeutic plan to avoid risks.

Differences in pain, symptom burden, and opioid use among cancer pain patients with active versus non-active disease.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. e20568-e20568
Author(s):  
Karina J Bouffard ◽  
Lakshmi Koyyalagunta ◽  
Salahardin Abdi ◽  
Mike Hernandez ◽  
Diane M. Novy
Keyword(s):  
Pain Management ◽  
Cancer Pain ◽  
Symptom Burden ◽  
Disease Status ◽  
Pain Medication ◽  
Categorical Variables ◽  
Opioid Use ◽  
Poor Appetite ◽  
Pain Patients ◽  
Active Disease

e20568 Background: Many cancer survivors with non-active disease suffer with pain and other symptoms. This study investigated differences in symptoms and opioid use among cancer pain patients with active versus non-active disease. Methods: Data were obtained from 518 consecutive new patients seen at the Pain Management Center of MD Anderson Cancer Center from 01/01/09 to 06/30/09. Measures: Usual pain was rated on the Brief Pain Inventory. The Edmonton Symptom Assessment Scale (ESAS) was used for ratings of fatigue, shortness of breath, poor appetite, depression, anxiety, drowsiness, difficulty thinking clearly and insomnia. Opioid use was calculated in morphine equivalency daily dose (MEDD) milligrams based on the sum of long- and short-acting opioids used per day. Analyses of Data: Independent samples t-tests were used to make comparisons between patients with active versus non-active disease on continuous variables. Chi-square tests were used to make comparisons across disease status on categorical variables. Results: 349 patients had active disease; 169 patients had non-active disease. Patients with active disease received significantly higher MEDD (125.6 ± 158.8 mg) versus patients with non-active disease (74.4 ± 87.0 mg). Patients with active disease reported significantly higher mean scores on fatigue, poor appetite, and drowsiness. Average weekly pain scores were comparable and moderately high for both groups of patients. Other symptoms and clinical characteristics were not significantly different across disease status. Conclusions: Plausible explanations for the higher opioid use and symptom burden among patients with active disease are cancer treatments and disease progression. A higher level of pain medication is often needed to achieve pain management during active treatment or following recent surgery. The finding of higher fatigue, poor appetite, and drowsiness among those with active disease is also consistent with the symptom burden expected from treatment. Although patients with active disease have a greater symptom burden and need for pain medication, there is a need for pain and symptom management among patients in the non-active disease phase of survivorship.

Perceived risk of opioid use disorder secondary to opioid analgesic medication use by the general population in France

2021 ◽  
Author(s):  
Justine Lavergne ◽  
Marion Debin ◽  
Thierry Blanchon ◽  
Vittoria Colizza ◽  
Lise Dassieu ◽  
...  
Keyword(s):  
General Population ◽  
Perceived Risk ◽  
Opioid Analgesic ◽  
Medication Use ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Analgesic Medication
Sign in / Sign up

Export Citation Format

Share Document